INSTITUTIONAL BIOSAFETY COMMITTEE REVIEW
Fate Therapeutics, Inc./FT819-102/Elsedawy/07-15-2026/Continuing Review 1 of 3 MEETING MINUTES Meeting Date: Wednesday, July 15, 2026 Time: 11:00 am Central Time Location: Zoom Teleconference Institution: Regional One Health, Memphis, TN Principal Investigator: Noura Elsedawy, MD Protocol: Fate Therapeutics, Inc., FT819-102 NCT Number: NCT06308978 Meeting Type: Continuing Review of Protocol and Site Title: A Phase 1 Study [...]
